Gregory Verdine is a leader in the discovery, development and commercialization of new drug modalities. A passionate and accomplished inventor of novel approaches and drug classes to engage targets widely believed intractable, Greg coined the phrase “drugging the undruggable” to describe his life mission. LifeMine is the brainchild of Greg, who as a venture partner of WuXi Healthcare Ventures, led the founding team that brought the company from concept to reality. In his role as President and CEO of LifeMine, Greg is leading the company through its ramp-up and march toward the clinic. Greg has served on the board of directors of Enanta Pharmaceuticals, Wave Life Sciences, Warp Drive Bio, and FOG Pharmaceuticals. Having led the formation and financing of Wave Life Sciences, Warp Drive Bio and FOG, Greg took a role in managing these companies as their president, chief executive officer and chief scientific officer. Greg earned his Ph.D. in chemistry from Columbia University, a B.S. in chemistry from St. Joseph’s University and served as an NIH postdoctoral fellow in molecular biology at MIT and Harvard Medical School.